BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9647243)

  • 21. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1.
    Cavanagh DR; McBride JS
    Mol Biochem Parasitol; 1997 Apr; 85(2):197-211. PubMed ID: 9106193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar.
    Kang JM; Moon SU; Kim JY; Cho SH; Lin K; Sohn WM; Kim TS; Na BK
    Malar J; 2010 May; 9():131. PubMed ID: 20478015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
    John CC; O'Donnell RA; Sumba PO; Moormann AM; de Koning-Ward TF; King CL; Kazura JW; Crabb BS
    J Immunol; 2004 Jul; 173(1):666-72. PubMed ID: 15210830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.
    Da Silveira LA; Dorta ML; Kimura EA; Katzin AM; Kawamoto F; Tanabe K; Ferreira MU
    Infect Immun; 1999 Nov; 67(11):5906-16. PubMed ID: 10531247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ; Richards JS; Simpson JA; Beeson JG
    PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diversity in the block 2 region of the merozoite surface protein-1 of Plasmodium falciparum in central India.
    Bharti PK; Shukla MM; Sharma YD; Singh N
    Malar J; 2012 Mar; 11():78. PubMed ID: 22439658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
    Dent A; Malhotra I; Mungai P; Muchiri E; Crabb BS; Kazura JW; King CL
    J Immunol; 2006 Nov; 177(10):7139-45. PubMed ID: 17082631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally acquired antibodies against the major merozoite surface coat protein (MSP-1) of Plasmodium falciparum acquired by residents in an endemic area of Colombia.
    Terrientes ZI; Kramer K; Herrera MA; Chang SP
    Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():55-61. PubMed ID: 7565133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
    PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity in merozoite surface protein-1 and 2 among Plasmodium falciparum isolates from malarious districts of tribal dominant state of Jharkhand, India.
    Hussain MM; Sohail M; Kumar R; Branch OH; Adak T; Raziuddin M
    Ann Trop Med Parasitol; 2011 Dec; 105(8):579-92. PubMed ID: 22325817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.
    Egan AF; Chappel JA; Burghaus PA; Morris JS; McBride JS; Holder AA; Kaslow DC; Riley EM
    Infect Immun; 1995 Feb; 63(2):456-66. PubMed ID: 7822010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.
    Hoffmann EH; da Silveira LA; Tonhosolo R; Pereira FJ; Ribeiro WL; Tonon AP; Kawamoto F; Ferreira MU
    Ann Trop Med Parasitol; 2001 Mar; 95(2):117-32. PubMed ID: 11299119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds.
    Egan A; Waterfall M; Pinder M; Holder A; Riley E
    Infect Immun; 1997 Aug; 65(8):3024-31. PubMed ID: 9234749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
    Burghaus PA; Wellde BT; Hall T; Richards RL; Egan AF; Riley EM; Ballou WR; Holder AA
    Infect Immun; 1996 Sep; 64(9):3614-9. PubMed ID: 8751907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The profile of IgG-antibody response against merozoite surface proteins 1 and 2 in severe Plasmodium falciparum malaria in Eastern Sudan.
    A-Elgadir TM; Elbashir MI; Berzins K; Masuadi EM; A-Elbasit IE; ElGhazali G; Giha HA
    Parasitol Res; 2008 Feb; 102(3):401-9. PubMed ID: 18038151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic diversity in merozoite surface protein (MSP)-1 and MSP-2 genes of Plasmodium falciparum in a major endemic region of Iran.
    Heidari A; Keshavarz H; Rokni MB; Jelinek T
    Korean J Parasitol; 2007 Mar; 45(1):59-63. PubMed ID: 17374980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype.
    Al-Yaman F; Genton B; Reeder JC; Mokela D; Anders RF; Alpers MP
    Am J Trop Med Hyg; 1997 Apr; 56(4):430-5. PubMed ID: 9158053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.